1. Fluorescence In Situ Hybridization-Based Chromosome Aberration Analysis Unveils the Mechanistic Basis for Boron-Neutron Capture Therapy's Radiobiological Effectiveness.
- Author
-
Elia, Valerio Cosimo, Fede, Francesca, Bortolussi, Silva, Cansolino, Laura, Ferrari, Cinzia, Formicola, Emilia, Postuma, Ian, and Manti, Lorenzo
- Subjects
BORON-neutron capture therapy ,CHROMOSOME abnormalities ,CHROMOSOME analysis ,LINEAR energy transfer ,NUCLEAR reactions ,CHROMOSOMES ,KARYOTYPES - Abstract
Boron-Neutron Capture Therapy (BNCT) is a tumor-selective radiotherapy, based on the nuclear capture reaction
10 B(n,α)7 Li producing short range α-particles and recoiling7 Li nuclei exclusively confined to boron-enriched cancer cells. These particles possess high Linear Energy Transfer (LET) and mainly generate clustered DNA strand breaks, which are less faithfully restored by intracellular repair. Mis-rejoined breaks yield chromosome aberrations (CAs), which, for high-LET radiation, are more complex in nature than after sparsely ionizing photons/electrons used in conventional radiotherapy, which leads to increased cell-killing ability. However, such a radiobiological tenet of BNCT has been scantily studied at the DNA level. Therefore, the aim of this work was to evaluate CAs induced by BNCT in comparison to X-rays in genomically stable normal human epithelial mammary MCF10A cells. Two Fluorescence In Situ Hybridization (FISH)-based techniques were applied to calyculin A-induced prematurely condensed chromosomes: Whole Chromosome Painting and multicolor(m)-FISH. Not only did BNCT induce a greater CA frequency than X-ray irradiation, but m-FISH karyotype-wide analysis confirmed that CAs following BNCT exhibited a much higher degree of complexity compared to X-rays. To our knowledge, this is the first time that such evidence supporting the radiobiological superiority of BNCT has been shown. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF